NCT02341690

Brief Summary

Type 2 Diabetes (T2D) is one of the most common chronic diseases world vide. Patients with T2D experiences reduced quality of life and have a lower physical activity level. Physical activity is well documented treatment to the patient group. The effect of physical activity is shown to reduce co-morbidity, and better functional level and quality of life. Interval Walking Training (IWT) is a new and effective exercise type. IWT is done by walking in a slow and a fast tempo. InterWalk is an application to a smartphone. By using InterWalk the patient can to IWT independently and when used, the app has, as an exercise tool, the potential to better the individual functional level and to measure the physical activity level with the integrated personalised walking test. Motivation for change of habits and lifestyle is subjectively determined by the individual, his or hers individual resources and environment. It is important to get insight in these individual challenges in order to be better structure possible help. The combination of an exercise log, a measure of physical activity fromInterWalk and insight in motivational aspects on an individual level, is essential for successful individualised training. The primary objective of the study is to investigate if the InterWalk app is more effective in increasing the physical activity level compared to a standard care offer in a sample of newly T2D diabetes patients across 52 weeks. Secondarily, we will investigate if the IW app can reduce sitting time, induce weight loss, improve glycaemic control, increase quality of life, improve cardio-respiratory fitness and reduce the use of diabetes medication. The study is designed to test the hypothesis that replacing a standard exercise program in the normal municipal standard care with the Interval Walking Training delivered by the IW app with and without a motivational support program, can increase the long-term physical activity level in patients with T2D for a period of 52 weeks. From January 2015 to June 2016 all patient's with T2D, who are referred to the promotion centres in the municipality, will be offered to participate in the study. In total 513 patients with T2D from different municipalities in Denmark will be included and randomly allocated into three groups. One group will receive standard care and the two other groups will do IWT with the InterWalk app. All three groups are followed by the promotion centre for 8-14 weeks (according to the rehabilitation in the municipality) and hereafter only one of the IWT groups will receive motivational support up to 52 weeks. All patients, no mater group allocation, will be tested and fulfill questionnaires, three times during the intervention period - at baseline, after 8-14 weeks and after 52 weeks. The interventions take place at the promotion centres in the municipalities two times a week and the patient will be encouraged train by them selves one time a week.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
226

participants targeted

Target at P75+ for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Jan 2015

Typical duration for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

January 9, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 19, 2015

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 17, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 17, 2017

Completed
Last Updated

May 24, 2018

Status Verified

May 1, 2018

Enrollment Period

3 years

First QC Date

January 9, 2015

Last Update Submit

May 23, 2018

Conditions

Keywords

Type 2 diabetesInterval Walking TrainingMotivation

Outcome Measures

Primary Outcomes (1)

  • Changes in Physical activity from baseline to 52 weeks, measured with accelerometrics

    Physical activity is measured with accelerometrics, where the patient wear two accelerometers (one on the thigh and one on the back) for 7 days at home, at baseline, after 8-14 weeks (according to the muncipality) and after 52 weeks.

    52 weeks

Secondary Outcomes (6)

  • Changes in VO2-peak from baseline to 52 weeks, measured by the standardised walking test (in the InterWalk)

    52 weeks

  • Change in Endurance in the lower extremities from baseline to 52 weeks, measured by sit-to-stand (30 seconds)

    January 2015 to July 2017

  • Changes in Self-rated physical activity from baseline to 52 weeks, measured by "The Resent Physical Activity Questionnaire" (RPAQ)

    52 weeks

  • Changes in Health related quality of life from baseline to 52 weeks, measured by SF-12

    52 weeks

  • Changes in Motivation for physical activity and behaviour change from baseline to 52 weeks, measured by the Behavioural exercise regulation questionnaire (BREQ-2).

    52 weeks

  • +1 more secondary outcomes

Other Outcomes (2)

  • Exploratory secondary outcome - Personality (measured once at baseline), measured by the NEO-Five Factor Inventory (NEO-FFI) and a Sensation Seeking Scale (SES).

    12 weeks

  • Changes in physical activity habits and diabetic motivation from baseline to 52 weeks - patients will be asked to answer 4 questions regarding their physical activity habits

    52 weeks

Study Arms (2)

Control

ACTIVE COMPARATOR

Standard rehabilitation with exercise

Other: control

Intervention (Interval Walking Training)

EXPERIMENTAL

Interval Walking Training with the InterWalk app, 3 times per week, 60 min. per sessions for 52 weeks. The intervention period is divided into 1. a period that follows standard care in the municipality (from 8-14 weeks according to the municipality. 2. a period (from week 8-14 to week 52) the patients will do Interval Walking on their own. 3. After the intervention at the promotion centre (8-14 weeks), the intervention group will be divided into to groups - a Interval Walking group (IWT) and a Interval Walking group with support (IWTsupport). IWTsupport: Patients in this group (after intervention at the promotion centre) will in addition to the IWT receive motivational support from week 8-14 to week 52 by the health professionals at the promotion centre.

Other: Interval walking training

Interventions

Interval Walking Training with the InterWalk Application An Interval-walking bout will consist of repeated cycles of 3 minutes of fast and 3 minutes of slow walking at 70% and 40% of the smart-phone assessed peak VO2-rate, respectively. IWT is conducted for at least 60 minutes per day, three days per week. Compliance is monitored continuously using the on-board accelerometer logger

Intervention (Interval Walking Training)
controlOTHER

Standard care at the promotion centre in the municipality

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients are eligible if they are diagnosed with T2D and are more than 18 years of age.

You may not qualify if:

  • Medical contraindications to exercise e.g. if the patient has developed chronic complications in the locomotive apparatus, e.g. painful osteoarthritis or heart conditions (30,39) and already is participating in other studies at the promotion centres concerning PA.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Copenhagen

Copenhagen, 1014, Denmark

Location

Related Publications (40)

  • Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010 Jan;87(1):4-14. doi: 10.1016/j.diabres.2009.10.007. Epub 2009 Nov 6.

    PMID: 19896746BACKGROUND
  • Unwin N, Gan D, Whiting D. The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract. 2010 Jan;87(1):2-3. doi: 10.1016/j.diabres.2009.11.006. Epub 2009 Dec 4. No abstract available.

    PMID: 19962207BACKGROUND
  • Sorensen HT, Friborg S, Rungby J, Christensen JS, Vaag A, Beck-Nielsen H. The Danish national type 2 diabetes cohort - the DD2 study. Clin Epidemiol. 2012;4(Suppl 1):1-5. doi: 10.2147/CLEP.S31104. Epub 2012 Sep 21. No abstract available.

    PMID: 23152706BACKGROUND
  • Pal K, Eastwood SV, Michie S, Farmer AJ, Barnard ML, Peacock R, Wood B, Inniss JD, Murray E. Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD008776. doi: 10.1002/14651858.CD008776.pub2.

    PMID: 23543567BACKGROUND
  • Thomsen RW, Friborg S, Nielsen JS, Schroll H, Johnsen SP. The Danish Centre for Strategic Research in Type 2 Diabetes (DD2): organization of diabetes care in Denmark and supplementary data sources for data collection among DD2 study participants. Clin Epidemiol. 2012;4(Suppl 1):15-9. doi: 10.2147/CLEP.S30082. Epub 2012 Sep 21.

    PMID: 23071407BACKGROUND
  • Pouwer F, Geelhoed-Duijvestijn PH, Tack CJ, Bazelmans E, Beekman AJ, Heine RJ, Snoek FJ. Prevalence of comorbid depression is high in out-patients with Type 1 or Type 2 diabetes mellitus. Results from three out-patient clinics in the Netherlands. Diabet Med. 2010 Feb;27(2):217-24. doi: 10.1111/j.1464-5491.2009.02903.x.

    PMID: 20546267BACKGROUND
  • Lloyd CE, Hermanns N, Nouwen A, Pouwer F, Underwood L, Winkley K. The epidemiology of depression and diabetes: In: Katon W, May M, Sartorius N, eds. Depression and Diabetes.Oxford:Wiley-Blackwell, 2010

    BACKGROUND
  • Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001 Sep 12;286(10):1218-27. doi: 10.1001/jama.286.10.1218.

    PMID: 11559268BACKGROUND
  • Karstoft K, Winding K, Knudsen SH, Nielsen JS, Thomsen C, Pedersen BK, Solomon TP. The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial. Diabetes Care. 2013 Feb;36(2):228-36. doi: 10.2337/dc12-0658. Epub 2012 Sep 21.

    PMID: 23002086BACKGROUND
  • Di Loreto C, Fanelli C, Lucidi P, Murdolo G, De Cicco A, Parlanti N, Ranchelli A, Fatone C, Taglioni C, Santeusanio F, De Feo P. Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. Diabetes Care. 2005 Jun;28(6):1295-302. doi: 10.2337/diacare.28.6.1295.

    PMID: 15920042BACKGROUND
  • Sone H, Tanaka S, Iimuro S, Tanaka S, Oida K, Yamasaki Y, Oikawa S, Ishibashi S, Katayama S, Yamashita H, Ito H, Yoshimura Y, Ohashi Y, Akanuma Y, Yamada N; Japan Diabetes Complications Study Group. Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study). Diabetologia. 2010 Mar;53(3):419-28. doi: 10.1007/s00125-009-1622-2. Epub 2010 Jan 7.

    PMID: 20054522BACKGROUND
  • Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports. 2006 Feb;16 Suppl 1:3-63. doi: 10.1111/j.1600-0838.2006.00520.x.

    PMID: 16451303BACKGROUND
  • Avery L, Flynn D, van Wersch A, Sniehotta FF, Trenell MI. Changing physical activity behavior in type 2 diabetes: a systematic review and meta-analysis of behavioral interventions. Diabetes Care. 2012 Dec;35(12):2681-9. doi: 10.2337/dc11-2452.

    PMID: 23173137BACKGROUND
  • Plotnikoff RC, Costigan SA, Karunamuni ND, Lubans DR. Community-based physical activity interventions for treatment of type 2 diabetes: a systematic review with meta-analysis. Front Endocrinol (Lausanne). 2013 Jan 29;4:3. doi: 10.3389/fendo.2013.00003. eCollection 2013.

    PMID: 23372566BACKGROUND
  • Conn VS, Hafdahl AR, Mehr DR, LeMaster JW, Brown SA, Nielsen PJ. Metabolic effects of interventions to increase exercise in adults with type 2 diabetes. Diabetologia. 2007 May;50(5):913-21. doi: 10.1007/s00125-007-0625-0. Epub 2007 Mar 7.

    PMID: 17342472BACKGROUND
  • Barnard KD, Peyrot M, Holt RI. Psychosocial support for people with diabetes: past, present and future. Diabet Med. 2012 Nov;29(11):1358-60. doi: 10.1111/j.1464-5491.2012.03727.x. No abstract available.

    PMID: 22681530BACKGROUND
  • Beck-Nielsen H, Henriksen JE. [Type 2 diabetes in Denmark]. Ugeskr Laeger. 2012 Sep 10;174(37):2132-8. Danish.

    PMID: 22971291BACKGROUND
  • de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD007459. doi: 10.1002/14651858.CD007459.pub2.

    PMID: 23235644BACKGROUND
  • Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL, Braun B; American College of Sports Medicine; American Diabetes Association. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 2010 Dec;33(12):2692-6. doi: 10.2337/dc10-1548. No abstract available.

    PMID: 21115771BACKGROUND
  • Little JP, Jung ME, Wright AE, Wright W, Manders RJ. Effects of high-intensity interval exercise versus continuous moderate-intensity exercise on postprandial glycemic control assessed by continuous glucose monitoring in obese adults. Appl Physiol Nutr Metab. 2014 Jul;39(7):835-41. doi: 10.1139/apnm-2013-0512. Epub 2014 Feb 18.

    PMID: 24773254BACKGROUND
  • El-Gayar O, Timsina P, Nawar N, Eid W. Mobile applications for diabetes self-management: status and potential. J Diabetes Sci Technol. 2013 Jan 1;7(1):247-62. doi: 10.1177/193229681300700130.

    PMID: 23439183BACKGROUND
  • El-Gayar O, Timsina P, Nawar N, Eid W. A systematic review of IT for diabetes self-management: are we there yet? Int J Med Inform. 2013 Aug;82(8):637-52. doi: 10.1016/j.ijmedinf.2013.05.006. Epub 2013 Jun 21.

    PMID: 23792137BACKGROUND
  • Ahlin K, Billhult A. Lifestyle changes - a continuous, inner struggle for women with type 2 diabetes: a qualitative study. Scand J Prim Health Care. 2012 Mar;30(1):41-7. doi: 10.3109/02813432.2011.654193. Epub 2012 Feb 12.

    PMID: 22324486BACKGROUND
  • Malpass A, Andrews R, Turner KM. Patients with Type 2 Diabetes experiences of making multiple lifestyle changes: a qualitative study. Patient Educ Couns. 2009 Feb;74(2):258-63. doi: 10.1016/j.pec.2008.08.018. Epub 2008 Oct 9.

    PMID: 18848413BACKGROUND
  • Welschen LM, van Oppen P, Dekker JM, Bouter LM, Stalman WA, Nijpels G. The effectiveness of adding cognitive behavioural therapy aimed at changing lifestyle to managed diabetes care for patients with type 2 diabetes: design of a randomised controlled trial. BMC Public Health. 2007 May 8;7:74. doi: 10.1186/1471-2458-7-74.

    PMID: 17488511BACKGROUND
  • Sarkar U, Fisher L, Schillinger D. Is self-efficacy associated with diabetes self-management across race/ethnicity and health literacy? Diabetes Care. 2006 Apr;29(4):823-9. doi: 10.2337/diacare.29.04.06.dc05-1615.

    PMID: 16567822BACKGROUND
  • Centis E, Trento M, Dei Cas A, Pontiroli AE, De Feo P, Bruno A, Sasdelli AS, Arturi F, Strollo F, Vigili De' Kreutzenberg S, Invitti C, Di Bonito P, Di Mauro M, Pugliese G, Molteni A, Marchesini G. Stage of change and motivation to healthy diet and habitual physical activity in type 2 diabetes. Acta Diabetol. 2014 Aug;51(4):559-66. doi: 10.1007/s00592-013-0551-1. Epub 2014 Jan 20.

    PMID: 24442514BACKGROUND
  • Ekelund U, Brage S, Griffin SJ, Wareham NJ; ProActive UK Research Group. Objectively measured moderate- and vigorous-intensity physical activity but not sedentary time predicts insulin resistance in high-risk individuals. Diabetes Care. 2009 Jun;32(6):1081-6. doi: 10.2337/dc08-1895. Epub 2009 Feb 27.

    PMID: 19252168BACKGROUND
  • Beck-Nielsen H, Solomon TP, Lauridsen J, Karstoft K, Pedersen BK, Johnsen SP, Nielsen JS, Kryger TB, Sortso C, Vaag A. The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) study: expected outcome from the DD2 project and two intervention studies. Clin Epidemiol. 2012;4(Suppl 1):21-6. doi: 10.2147/CLEP.S30655. Epub 2012 Sep 21.

    PMID: 23071408BACKGROUND
  • Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999 Jun;70(2):113-9. doi: 10.1080/02701367.1999.10608028.

    PMID: 10380242BACKGROUND
  • Besson H, Brage S, Jakes RW, Ekelund U, Wareham NJ. Estimating physical activity energy expenditure, sedentary time, and physical activity intensity by self-report in adults. Am J Clin Nutr. 2010 Jan;91(1):106-14. doi: 10.3945/ajcn.2009.28432. Epub 2009 Nov 4.

    PMID: 19889820BACKGROUND
  • Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996 Mar;34(3):220-33. doi: 10.1097/00005650-199603000-00003.

    PMID: 8628042BACKGROUND
  • Golubic R, May AM, Benjaminsen Borch K, Overvad K, Charles MA, Diaz MJ, Amiano P, Palli D, Valanou E, Vigl M, Franks PW, Wareham N, Ekelund U, Brage S. Validity of electronically administered Recent Physical Activity Questionnaire (RPAQ) in ten European countries. PLoS One. 2014 Mar 25;9(3):e92829. doi: 10.1371/journal.pone.0092829. eCollection 2014.

    PMID: 24667343BACKGROUND
  • Mortensen EL, Flensborg-Madsen T, Molbo D, Christensen U, Osler M, Avlund K, Lund R. Personality in late midlife: associations with demographic factors and cognitive ability. J Aging Health. 2014 Feb;26(1):21-36. doi: 10.1177/0898264313519317.

    PMID: 24584258BACKGROUND
  • KOLIN EA, PRICE L, ZOOB I. DEVELOPMENT OF A SENSATION-SEEKING SCALE. J Consult Psychol. 1964 Dec;28:477-82. doi: 10.1037/h0040995. No abstract available.

    PMID: 14242306BACKGROUND
  • Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010 Mar 23;340:c332. doi: 10.1136/bmj.c332.

    PMID: 20332509BACKGROUND
  • Siegert RJ, Taylor WJ. Theoretical aspects of goal-setting and motivation in rehabilitation. Disabil Rehabil. 2004 Jan 7;26(1):1-8. doi: 10.1080/09638280410001644932.

    PMID: 14660192BACKGROUND
  • Meyer PJ. "What would you do if you knew you couldn't fail? Creating S.M.A.R.T. Goals". Attitude is everything: If you want to succeed above and beyond. Meyer Resource Group Incorporated, ISBN 978-0-89811-304-4

    BACKGROUND
  • Thorsen IK, Yang Y, Valentiner LS, Glumer C, Karstoft K, Brond JC, Nielsen RO, Brons C, Christensen R, Nielsen JS, Vaag AA, Pedersen BK, Langberg H, Ried-Larsen M. The Effects of a Lifestyle Intervention Supported by the InterWalk Smartphone App on Increasing Physical Activity Among Persons With Type 2 Diabetes: Parallel-Group, Randomized Trial. JMIR Mhealth Uhealth. 2022 Sep 28;10(9):e30602. doi: 10.2196/30602.

  • Valentiner LS, Ried-Larsen M, Karstoft K, Brinklov CF, Brons C, Nielsen RO, Christensen R, Nielsen JS, Vaag AA, Pedersen BK, Langberg H. Long-term effect of smartphone-delivered Interval Walking Training on physical activity in patients with type 2 diabetes: protocol for a parallel group single-blinded randomised controlled trial. BMJ Open. 2017 Apr 7;7(4):e014036. doi: 10.1136/bmjopen-2016-014036.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Laura S Valentiner

    University of Copenhagen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD-student

Study Record Dates

First Submitted

January 9, 2015

First Posted

January 19, 2015

Study Start

January 1, 2015

Primary Completion

December 17, 2017

Study Completion

December 17, 2017

Last Updated

May 24, 2018

Record last verified: 2018-05

Locations